Guido Moll

Charité Universitätsmedizin Berlin, Germany
Title: Cryopreserved or Fresh Therapeutic Mesenchymal Stroma Cells? Past, Present and Future.


During the past decade, Guido Moll has studied in collaboration with leading clinical stem cell and tissue engineering pioneers the immunomodulatory and

regenerative properties of human multipotent mesenchymal stromal cells (MSCs) and other advanced therapy medicinal products (ATMPs) in a highly translational

research environment at the Karolinska Institute in Stockholm, Sweden, the Berlin-Brandenburg Center/School for Regenerative Therapies (BCRT/BSRT) at the

Charité Universitätsmedizin Berlin, Germany, and the Queensland Institute for Medical Research (QIMR) in Brisbane, Australia. The goal of Guido’s research is to

enhance the safety and efficacy of novel ATMPs in various therapeutic approaches.

Research Interest

No Content found...